- Filed
- Oct 15, 2021 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2022 · Aug 31, 2021 | 5.88M sh |
| Cash And Equivalents | Q2 2022 · Aug 31, 2021 | $245K |
| Cash And Equivalents | Q2 2022 · Feb 28, 2021 | $293K |
| Cash And Equivalents | Q2 2022 · Aug 31, 2020 | $414K |
| Cash And Equivalents | Q2 2022 · Feb 29, 2020 | $844K |
| Current Liabilities | Q2 2022 · Aug 31, 2021 | $4.13M |
| Current Liabilities | Q2 2022 · Feb 28, 2021 | $3.85M |
| Total Liabilities | Q2 2022 · Aug 31, 2021 | $4.65M |
| Total Liabilities | Q2 2022 · Feb 28, 2021 | $5.63M |
| Current Assets | Q2 2022 · Aug 31, 2021 | $6.3M |
| Current Assets | Q2 2022 · Feb 28, 2021 | $7.45M |
| Total Assets | Q2 2022 · Aug 31, 2021 | $8.34M |
| Total Assets | Q2 2022 · Feb 28, 2021 | $9.9M |
| Shares Diluted | Q2 2022 · Aug 31, 2020 | 5.88M sh |
| Shares Diluted | Q2 2022 · Aug 31, 2020 | 5.88M sh |
| Capex | Q2 2022 · Aug 31, 2020 | $31K |
| Operating Cash Flow | Q2 2022 · Aug 31, 2020 | −$1.53M |
| Stockholders Equity | Q2 2022 · Aug 31, 2020 | $2.45M |
| Stockholders Equity | Q2 2022 · May 31, 2020 | $3.46M |
| Stockholders Equity | Q2 2022 · Feb 29, 2020 | $3.46M |
| Eps Diluted | Q2 2022 · Aug 31, 2020 | −$0.17 |
| Eps Diluted | Q2 2022 · Aug 31, 2020 | −$0.17 |
| Eps Basic | Q2 2022 · Aug 31, 2020 | −$0.17 |
| Eps Basic | Q2 2022 · Aug 31, 2020 | −$0.17 |
| Sga Expense | Q2 2022 · Aug 31, 2020 | $976K |
| Sga Expense | Q2 2022 · Aug 31, 2020 | $1.97M |
| Net Income | Q2 2022 · Aug 31, 2020 | −$1M |
| Net Income | Q2 2022 · Aug 31, 2020 | −$1.01M |
| Operating Income | Q2 2022 · Aug 31, 2020 | −$1.08M |
| Operating Income | Q2 2022 · Aug 31, 2020 | −$1.31M |
| Gross Profit | Q2 2022 · Aug 31, 2020 | $185K |
| Gross Profit | Q2 2022 · Aug 31, 2020 | $1.16M |
| Cost Of Revenue | Q2 2022 · Aug 31, 2020 | $2.11M |
| Cost Of Revenue | Q2 2022 · Aug 31, 2020 | $4.83M |
| Revenue | Q2 2022 · Aug 31, 2020 | $2.29M |
| Revenue | Q2 2022 · Aug 31, 2020 | $6M |